What Are Alpha-Glucosidase Inhibitors for Diabetes? - WebMD
网页2023年5月21日 · Alpha-glucosidase inhibitors are pills that treat type 2 diabetes. There are two medications in this group, or class, of drugs: acarbose (Precose) and miglitol (Glyset). They help keep the...
α-Glucosidase Inhibitors for Patients With Type 2 Diabetes
网页2005年1月1日 · Alpha-glucosidase inhibitors (AGIs; acarbose, miglitol, voglibose) are widely used in the treatment of patients with type 2 diabetes. AGIs delay the absorption of carbohydrates from the small intestine and thus have a lowering effect on postprandial blood glucose and insulin levels.
Gliclazide: a medicine to treat type 2 diabetes - NHS
网页Find out how gliclazide treats type 2 diabetes and how to take it. About gliclazide. Who can and cannot take it. How and when to take it. Side effects. Pregnancy, breastfeeding and fertility. Taking gliclazide with other medicines and herbal supplements. Common questions. Related conditions.
Alpha-glucosidase inhibitors for treatment of diabetes mellitus
网页2024年1月4日 · Alpha-glucosidase inhibitors lower blood glucose by modifying the intestinal absorption of carbohydrates. The glycemic efficacy, adverse effects, and dosing of alpha-glucosidase inhibitors will be discussed here. Other oral hypoglycemic drugs are reviewed separately.
Glycosides and Vascular Complications of Diabetes
网页Nephropathy, neuropathy and retinopathy are important microvascular complications of diabetes. Different types of secondary metabolites including glycosides have been studied for their effects in diabetic complications. Various glycosides such as flavanoid glycosides and saponin glycosides are reported for their beneficial effects in diabetic ...
In the Search of Glycoside-Based Molecules as Antidiabetic Agents
网页2019年6月5日 · First, the O-glycosides used in the treatment of diabetes are presented, followed by the N-glycosides and finally the C-glycosides constituting the largest group of antidiabetic drugs are described. Within each group of glycosides, we presented how the structure of compounds representing potential drugs changes and when discussing chemical ...
Alpha Glucosidase Inhibitors - StatPearls - NCBI Bookshelf
网页2024年2月28日 · Alpha-glucosidase inhibitors (AGIs) are therapeutic agents in managing type 2 diabetes. Acarbose and miglitol are FDA-approved and are prominent members of this drug class. AGIs are also prescribed for patients with impaired glucose tolerance, demonstrating their utility in delaying the onset of diabetes in this cohort.
Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms …
网页2019年9月1日 · An experimental study proposed that isorhamnetin glycoside has several effects on diabetes, like stimulating insulin secretion, the expression of enzymes involved in lipid metabolism, and the expression of endoplasmic reticulum stress markers [103,104].
Pharmacologic Glycemic Management of Type 2 Diabetes in …
网页The update on pharmacotherapy for type 2 diabetes is only one part of our clinical practice guidelines (CPG) which aim to take a holistic, patient-centred approach. Reducing microvascular and cardiovascular (CV) complications, improving quality of life, relieving symptoms of hyperglycemia and reducing risk of hypoglycemia are all important ...
Pharmacologic Glycemic Management of Type 2 Diabetes in …
网页What’s New in 2020. First, additional agents approved for use in Canada have been shown to have cardiovascular (CV) benefits in patients with type 2 diabetes. Second, some of these CV benefits have now been demonstrated in people with CV risk factors but without established atherosclerotic cardiovascular disease (ASCVD).
跳至内容